To consider why the burden of depression persists.
Method:
The epidemiology and disability associated with depression were reviewed to consider whether depression persists because: the causes are overwhelming, prevention is ineffective, the disease is difficult to detect or diagnose, the condition remits and recurs, treatments do not work, individuals do not seek treatment, or effective care is not provided when they do seek it.
Results:
The first 5 possibilities were not considered significant reasons for the persistence of the burden.
Conclusion:
The burden persists because individuals do not seek treatment for their depression when they relapse and effective proactive treatment is not always provided when they do seek it.
Objectif:
Examiner pourquoi le fardeau de la dépression persiste.
Méthode:
L'épidémiologie et l'incapacité associées à la dépression ont été examinées pour déterminer si la dépression persiste parce que: les causes sont accablantes, la prévention est inefficace, la maladie est difficile à détecter ou à diagnostiquer, l'affection entre en rémission et revient, les traitements ne fonctionnent pas, les personnes ne veulent pas de traitement, ou des soins efficaces ne sont pas dispensés quand elles en veulent.
Résultats:
Les 5 premières possibilités n'ont pas été considérées comme étant des raisons significatives de la persistance du fardeau.
Conclusion:
Le fardeau persiste parce que les personnes ne veulent pas de traitement pour leur dépression quand elles rechutent, et qu'un traitement proactif efficace n'est pas toujours dispensé quand elles en veulent.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): APA; 1994.
2.
AndrewsGHendersonSHallW.Prevalence, comorbidity, disability and service utilisation. Overview of the Australian National Mental Health Survey. Br J Psychiatry. 2001;178:145–153.
3.
KilohLGAndrewsGNielsonMD. The long term outcome of depression. Br J Psychiatry. 1988;153:752–757.
4.
LeeASMurrayRM. The long-term outcome of Maudsley depressives. Br J Psychiatry. 1988;155:741–751.
5.
JuddLLHagopSAMaserJD, A prospective 12 year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry. 1998;55:694–700.
6.
CuijpersPSmitF.Subthreshold depression as a risk indicator for major depressive disorder: A systematic review of prospective studies. Acta Psychiatr Scand. 2004;109:325–331.
7.
KesslerKSZhaoSBlazerDG, Prevalence, correlates and course of minor depression and major depression in the national comorbidity survey. J Affective Disord. 1997;45:19–30.
8.
UstenTBAyuso-MateosJLChatterjiS, Global burden of depressive disorders in the year 2000. Br J Psychiatry. 2004;184:386–392.
9.
AndrewsG.Should depression be managed as a chronic disease?BMJ. 2001;322:419–421.
10.
KruijshaarMEBarendregtJVosT, Lifetime prevalence estimates of major depression: An indirect estimation method and a quantification of recall bias. Eur J Epidemiol. 2005;20:103–111.
11.
JaffeeSRMoffittTECaspiA, Differences in early childhood risk factors for juvenile-onset and adult-onset depression. Arch Gen Psychiatry. 2002;59:215–222.
PalssonSPOstlingSSkoogI.The incidence of first-onset depression in a population followed from the age 70 to 85. Psychol Med. 2001;31:1159–1168.
14.
AndrewsGPoultonRSkoogI.Lifetime risk of depression: Restricted to a minority or waiting for most?Br J Psychiatry. 2005;187:495–496.
15.
MoussaviSChatterjiSVerdesE, Depression, chronic disease and decrements in health: Evidence from the World Health Surveys. Lancet. 2007;369:851–858.
16.
MurrayCJLLopezA, editors. The global burden of disease. Cambridge (MA): Harvard University Press; 1996.
17.
MathersCVosTSteversonC.The burden of disease and injury in Australia. Canberra (ACT): AIHW; 1999.
18.
MathersCLopezASteinC, Deaths and disease burden by cause. CDPP working paper 18. Bethesda (MD): National Institute of Health; 2004.
19.
SullivanPFNealeMCKendlerKS. Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry. 2000;157:1552–1562.
20.
GrossCHenR.The developmental origins of anxiety. Nature Reviews. 2004;5:545–552.
21.
KendlerKSKarkowskiLMPrescottCA. Causal relationship between stressful life events and the onset of major depression. Am J Psychaitry. 1999;156:837–841.
22.
PoultonRGAndrewsG.Change in danger cognitions in agoraphobia and social phobia during treatment. Behav Res Ther. 1996;34:413–421.
23.
AndrewsGCorryJSladeT, Child sexual abuse. In: EzzatiMLopezADRodgersA, editors. Comparative quantification of health risksvolume 2. Geneva (CH): World Health Organization; 2004. p 1851–1940.
24.
CaspiASugdenKMoffittTE, Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–389.
25.
ZimmermanPBrucklTLiebR, The interplay of familial depression liability and adverse events in predicting the first onset of depression during a ten-year follow-up. Biol Psychiatry. 2008;63:406–414.
26.
The WHO World Mental Health Survey Consortium. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health surveys. JAMA. 2004;291:2581–2590.
27.
NesseRM. Evolutionary explanations for mood and mood disorders. In: SteinDJKupfurDJSchatzbergAF, editors. American psychiatric publishing textbook of mood disorders. Washington (DC): American Psychiatric Publishing; 2006. p 159–175.
28.
ParkerG.Beyond major depression. Psychol Med. 2005;35:467–474.
29.
AndrewsGSzaboMBurnsJ.Preventing major depression in young people. Br J Psychiatry. 2002;181:460–462.
30.
AndrewsGWilkinsonDD. The prevention of mental disorders in young people. Med J Aust. 2002;177:S97–S100.
31.
CuijpersPVan StratenASmitF.Preventing the incidence of new cases of mental disorders: A meta-analytic review. J Nerv Ment Dis. 2005;193:119–125.
32.
AndrewsGVan VlietHWuthrichV.The reduction of anxiety in school children: Preliminary results withwww.climateschools.tv. In: CastleDHoodSKyriosM, editors. Anxiety disorders: Current controversies, future directions. Fitzroy (AUS): Australian Postgraduate Medicine; 2007. p 149–159.
33.
ZimmermanMChelminskiIMcGlincheyJB, Diagnosing major depressive disorder X: Can the utility of the DSM-IV symptom criteria be improved?J Nerv Ment Dis. 2006;194:893–897.
34.
AndrewsGSladeTSunderlandM, Issues for DSM-V: Simplifying DSM-IV to enhance utility: The case of major depressive disorder. Am J Psychiatry. 2007;164:1784–1785.
35.
AndrewsGStewartGWMorris-YatesA, Evidence for a general neurotic syndrome. Br J Psychiatry. 1990;157:6–12.
36.
AndrewsGSladeTIssakidisC.Deconstructing current comorbidity: Data from the Australian National Survey of Mental Health and Well-being. Br J Psychiatry. 2002;181:306–314.
37.
SladeTWatsonD.The structure of common DSM-IV and ICD-10 mental disorders in the Australian general population. Psychol Med. 2006;36:1593–1600.
38.
UstunTBSartoriusN, editors. Mental illness in general health care: An international study. London (GB): John Wiley & Sons; 1995.
39.
SakashitaCSladeTAndrewsG.An empirical analysis of 2 assumptions in the diagnosis of DSM-IV Major Depression Episode. Aust NZ J Psychiatry. 2007;41:17–23.
40.
KraemerHCShroutPRubio-StipecM.Developing the diagnostic and statistical manual V: What will “statistical” mean in DSM-V?Soc Psychiatry Psychiatr Epidemiol. 2007;42(4):259–267.
41.
AndrewsGAndersonTSladeT, Classification of anxiety and depressive disorders: Do you want to be right or want to be effective? Depress Anxiety. Forthcoming 2008 May.
42.
KroenkeKSpitzerRL. The PHQ-9: A new depression diagnostic and severity measure. Psychiatr Ann. 2002;32:1–7.
43.
KroenkeKSpitzerRLWiliamsJBW. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613.
44.
KesslerDLloydKLewisG, Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care. BMJ. 1999;318:436–440.
45.
KirmayerLJRobbinsJMDworkindM, Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry. 1993;150:734–741.
46.
National Institute for Clinical Excellence. Depression: Management of depression in primary and secondary care—NICE guidance. Report CG23. London (GB): National Institute for Health and Clinical Excellence; 2004.
47.
AHCPR depression guideline panel. Depression in primary care: Detection, diagnosis, and treatment. Technical report no 5. Rockville (MD): US Department of Health and Human Services, Public Health Service; 2000.
48.
RushJAMaurizioFBWisniewskiSR, Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design. Control Clin Trials. 2004;25:119–142.
49.
SimonJPillingSBurbeckR, Treatment options in moderate and severe depression: Decision analysis supporting a clinical guideline. Br J Psychiatry. 189:494–501.
50.
JormAF. Mental health literacy: Public knowledge and beliefs about mental disorders. Br J Psychiatry. 2000;177:396–401.
51.
WagnerEHAustinBTVon Korff. Organizing care for patients with chronic illness. Millbank Q. 1996;74:511–543.
52.
KatonWVon KorffMLinE, Population based care of depression: Effective disease management strategies to decrease prevalence. Gen Hosp Psychiatry. 1997;19:169–178.
53.
WhittyPGilbodyS.NICE, but will they help people with depression? The new National Institute for Clinical Excellence depression guidelines. Br J Psychiatry. 2005;186:177–178.
54.
GilbodySBowerPWhittyP.Costs and consequences of enhanced primary care for depression. Br J Psychiatry. 2006;189:297–308.
55.
GilbodySBowerPFletcherJ, Collaborative care for depression: A cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med. 2006;166:2314–2321.
56.
DietrichAJOxmanTEWilliamsJW, Re-engineering systems for the treatment of depression in primary care: Cluster randomized controlled trial. BMJ. 2004;329:602–607.
